Charlton, MH;
Aleksis, R;
Saint-Leger, A;
Gupta, A;
Loza, E;
Ribas de Pouplana, L;
Kaula, I;
Gustina, D;
Madre, M;
Lola, D;
et al.
Charlton, MH; Aleksis, R; Saint-Leger, A; Gupta, A; Loza, E; Ribas de Pouplana, L; Kaula, I; Gustina, D; Madre, M; Lola, D; Jaudzems, K; Edmund, G; Randall, CP; Kime, L; O'Neill, AJ; Goessens, W; Jirgensons, A; Finn, PW
(2018)
N-Leucinyl Benzenesulfonamides as Structurally Simplified Leucyl-tRNA Synthetase Inhibitors.
ACS Med Chem Lett, 9 (2).
pp. 84-88.
ISSN 1948-5875
https://doi.org/10.1021/acsmedchemlett.7b00374
SGUL Authors: Gupta, Arya
![[img]](https://openaccess.sgul.ac.uk/109807/1.hassmallThumbnailVersion/Charlton_2018_N-Leucinyl.pdf) ![](https://openaccess.sgul.ac.uk/109807/1.haspreviewThumbnailVersion/Charlton_2018_N-Leucinyl.pdf) Preview |
|
PDF
Accepted Version
Available under License ["licenses_description_publisher" not defined].
Download (195kB)
| Preview
|
Abstract
N-Leucinyl benzenesulfonamides have been discovered as a novel class of potent inhibitors of E. coli leucyl-tRNA synthetase. The binding of inhibitors to the enzyme was measured by using isothermal titration calorimetry. This provided information on enthalpy and entropy contributions to binding, which, together with docking studies, were used for structure-activity relationship analysis. Enzymatic assays revealed that N-leucinyl benzenesulfonamides display remarkable selectivity for E. coli leucyl-tRNA synthetase compared to S. aureus and human orthologues. The simplest analogue of the series, N-leucinyl benzenesulfonamide (R = H), showed the highest affinity against E. coli leucyl-tRNA synthetase and also exhibited antibacterial activity against Gram-negative pathogens (the best MIC = 8 μg/mL, E. coli ATCC 25922), which renders it as a promising template for antibacterial drug discovery.
Statistics
Item downloaded times since 14 Jan 2020.
Actions (login required)
![Edit Item](/style/images/action_view.png) |
Edit Item |